Published on
Oncology-Genetic Predisposition to Cancer
I. Increased Cancer Risk in Families:
  • Moderate Increase: Epidemiological studies show a 2-3 times higher cancer risk among first-degree relatives of cancer patients. This isn't always due to inherited gene alterations; shared environmental factors or increased susceptibility to carcinogens also play a role.
II. Recognizing Familial Cancers:
Familial cancers may be indicated by several factors:
  • Rare, Genetic Cancers: Examples include bilateral retinoblastoma.
  • Associated Phenotypic Features: These are observable physical characteristics associated with specific genetic syndromes, such as:
    • FAP (Familial Adenomatous Polyposis): Multiple polyps.
    • Peutz-Jeghers Syndrome: Mucosal pigmentation.
    • DNA Repair Disorders: Chromosome breakage.
  • Family History Clues: These suggest a higher likelihood of inherited predisposition:
    • Early Onset: Cancer diagnosed at an unusually young age.
    • Multiple or Bilateral Tumors: More than one tumor, or tumors on both sides of the body (e.g., both breasts).
    • Familial Clustering: Multiple family members with the same or related cancers (e.g., breast and ovarian cancer; colon and uterine cancer).
III. Suspicious Family Histories: The following family histories warrant further investigation (referral to clinical genetics):
  • Three or more close relatives (same side of family) with the same common cancer (or related cancers).
  • Two or more close relatives (same side of family) with the same common cancer (or related cancers), with at least one diagnosis before age 50.
  • One close relative with early-onset cancer (e.g., breast cancer <40, bowel cancer <45).< />pan>
  • One close relative with multiple primary cancers.
  • Two or more relatives with the same uncommon cancer (e.g., sarcoma, glioma, pancreatic cancer).
IV. Clinical Evaluation and Genetic Testing:
  • Clinical Examination: May reveal specific features of genetic syndromes like Cowden syndrome, Gorlin syndrome, or neurofibromatosis. Know the characteristic features of each.
  • Genetic Testing: Possible only when a causative germline mutation can be identified in a blood sample from an affected relative. Often, testing isn't possible due to:
    • Lack of a suspected mutation in known predisposition genes.
    • Unavailability of samples from affected relatives.
    • Failure to identify the causative mutation in relevant genes.
  • Cancer Surveillance: May be arranged for at-risk relatives, but effectiveness is often unproven. Participation in relevant clinical trials is encouraged.
V. Key Terms and Concepts to Master:
  • Germline mutation: A mutation present in an organism's germ cells (sperm or eggs), which can be passed on to offspring.
  • Phenotypic features: Observable physical characteristics.
  • Familial clustering: The occurrence of the same or related cancers in multiple members of a family.
  • Early-onset cancer: Cancer diagnosed at a younger age than typically expected.
  • Bilateral tumors: Tumors occurring on both sides of the body.
  • Clinical genetics services: Specialized medical services that evaluate and manage inherited conditions, including cancer predisposition.
Picture
0 Comments